Akhmed Aslam

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Diabetic Nephropathy

Psychometric Properties

Top Venues

International journal of molecular sciences

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Abdulrahman Mujalli, Wesam F Farrash, Ahmad A Obaid, Anmar A Khan, Riyad Adnan Almaimani, Shakir Idris, Mohamed Elzubier Elzubier, Elshiekh Babiker A Khidir, Akhmed Aslam, Faisal Minshawi, Mohammad A Alobaidy, Adel B Alharbi, Hussain A Almasmoum, Mazen Ghaith, Khalid M Alquthami, Bassem Refaat
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus. International journal of molecular sciences 24 (24) (2023)
Saeed M Kabrah, Samer Abuzerr, Ruba Omar Almaghrabi, Raed F Alserihi, Raed I Felimban, Abdulrahman Mujalli, Akhmed Aslam, Bassem Refaat, Amr Jamal Halawani, Adel A Alzhrani, Naif Samran AlMoteri, Fauziah Fawzi Abusaadh, Rasha A Bulkhi
The Quality of Blood Donation Services and Its Association with Blood Donors' Trust and Loyalty at Makkah Blood Donation Centers in Saudi Arabia: A Cross-Sectional Study. Healthcare (Basel, Switzerland) 11 (15) (2023)
Abdulrahman Mujalli, Wesam F Farrash, Ahmad A Obaid, Anmar A Khan, Riyad Adnan Almaimani, Shakir Idris, Mohamed Elzubier Elzubier, Elshiekh Babiker A Khidir, Akhmed Aslam, Faisal Minshawi, Mohammad A Alobaidy, Adel B Alharbi, Hussain A Almasmoum, Mazen Ghaith, Khalid M Alquthami, Bassem Refaat
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus. International journal of molecular sciences 24 (24) (2023)
Riyad Adnan Almaimani, Akhmed Aslam, Jawwad Ahmad, Mahmoud Zaki El-Readi, Mohamed E El-Boshy, Abdelghany H Abdelghany, Shakir Idris, Mai Alhadrami, Mohammad Althubiti, Hussain A Almasmoum, Mazen M Ghaith, Mohamed E Elzubeir, Safaa Yehia Eid, Bassem Refaat
In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D 3 , and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the PI3K/Akt/PTEN/mTOR Network. Cancers 14 (6) (2022)